Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Pulse Biosciences (PLSE) PT Lowered to $43 at H.C. Wainwright
November 16, 2021 6:38 AM ESTH.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on Pulse Biosciences (NASDAQ: PLSE) to $43.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "Pulse reported 3Q21 financial results and held a conference call on November 15. During the quarter, while Pulse is... More
